Differential cell photosensitivity following porphyrin photodynamic therapy

Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair, as well as for cells which make up components of the vasculature. Photofrin II is undergoing current clinical evaluation for photodynamic the...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Vol. 48; no. 16; pp. 4539 - 4542
Main Authors: GOMER, C. J, RUCKER, N, MURPHREE, A. L
Format: Journal Article
Language:English
Published: Philadelphia, PA American Association for Cancer Research 15-08-1988
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair, as well as for cells which make up components of the vasculature. Photofrin II is undergoing current clinical evaluation for photodynamic therapy of solid tumors, and therefore the retention, dark toxicity, and photosensitizing effects of this drug on human DNA repair-deficient fibroblasts (ataxia telangiectasia and xeroderma pigmentosum) were compared to normal human fibroblasts. In addition, bovine cells of endothelial, smooth muscle, and fibroblast origin were compared for porphyrin retention, toxicity, and photosensitivity. All human fibroblasts exhibited porphyrin-induced dark toxicity, but there were no significant differences in photosensitization or porphyrin retention for any of these cell lines. However, bovine endothelial cells were considerably more photosensitive than smooth muscle or fibroblast cells treated under identical conditions. All bovine cells accumulated similar levels of porphyrin, and therefore the increased sensitivity of the endothelial cells was not due to differences in porphyrin retention. These results provide additional evidence that nuclear damage and/or repair is not a dominant factor in the cytotoxicity induced by porphyrin photosensitization. In addition, these results indicate that endothelial cell photosensitivity may play a role in the vascular damage observed following photodynamic therapy.
AbstractList Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair, as well as for cells which make up components of the vasculature. Photofrin II is undergoing current clinical evaluation for photodynamic therapy of solid tumors, and therefore the retention, dark toxicity, and photosensitizing effects of this drug on human DNA repair-deficient fibroblasts (ataxia telangiectasia and xeroderma pigmentosum) were compared to normal human fibroblasts. In addition, bovine cells of endothelial, smooth muscle, and fibroblast origin were compared for porphyrin retention, toxicity, and photosensitivity. All human fibroblasts exhibited porphyrin-induced dark toxicity, but there were no significant differences in photosensitization or porphyrin retention for any of these cell lines. However, bovine endothelial cells were considerably more photosensitive than smooth muscle or fibroblast cells treated under identical conditions. All bovine cells accumulated similar levels of porphyrin, and therefore the increased sensitivity of the endothelial cells was not due to differences in porphyrin retention. These results provide additional evidence that nuclear damage and/or repair is not a dominant factor in the cytotoxicity induced by porphyrin photosensitization. In addition, these results indicate that endothelial cell photosensitivity may play a role in the vascular damage observed following photodynamic therapy.
Author RUCKER, N
MURPHREE, A. L
GOMER, C. J
Author_xml – sequence: 1
  givenname: C. J
  surname: GOMER
  fullname: GOMER, C. J
  organization: Children's hosp., Clayton ocular oncology cent., Los Angeles CA 90027, United States
– sequence: 2
  givenname: N
  surname: RUCKER
  fullname: RUCKER, N
  organization: Children's hosp., Clayton ocular oncology cent., Los Angeles CA 90027, United States
– sequence: 3
  givenname: A. L
  surname: MURPHREE
  fullname: MURPHREE, A. L
  organization: Children's hosp., Clayton ocular oncology cent., Los Angeles CA 90027, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7855583$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/2969280$$D View this record in MEDLINE/PubMed
BookMark eNo9j0tLxDAYRYOMjJ3RnyB04baQNM8uZXyMOOBC90PafLGRNC1JVPrvHZji6nI5hwt3g1ZhDHCBCsKpqiRjfIUKjLGqOJP1Fdqk9HWqnGC-Ruu6EU2tcIFeH5y1ECFkp33Zgffl1I95TBCSy-7H5bm0o_fjrwuf5TTGqZ-jC2fJzEEPritzD1FP8zW6tNonuFlyi96fHj92--rw9vyyuz9UfS2aXBGiOFiFSccMVYbQmuNacKCYUZC0hZa1hmHccSOkNaTRoKxSVAoFVNAtuj2vTt_tAOY4RTfoOB-XSyd-t3CdOu1t1KFz6V-TinOuKP0DIwFYtA
CODEN CNREA8
ContentType Journal Article
Copyright 1988 INIST-CNRS
Copyright_xml – notice: 1988 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1538-7445
EndPage 4542
ExternalDocumentID 2969280
7855583
Genre Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S
Journal Article
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA-31230
– fundername: NCI NIH HHS
  grantid: CA-44733
GroupedDBID ---
-ET
.55
.GJ
08R
18M
29B
2WC
34G
39C
3O-
476
53G
5GY
5RE
5VS
6J9
8WZ
A6W
AAPBV
AAUGY
ABOCM
ABPTK
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AETEA
AFFNX
AFHIN
AFOSN
AFRAH
AI.
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
C1A
CS3
D0S
DIK
DU5
EBS
EJD
F5P
FRP
GX1
H13
IH2
IQODW
J5H
KQ8
L7B
LSO
MVM
OHT
OK1
P0W
P2P
PQQKQ
RCR
RHF
RHI
RNS
SJN
TR2
UDS
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
XFK
XJT
YKV
YZZ
ZA5
ZCG
ZGI
CGR
CUY
CVF
ECM
EIF
NPM
ID FETCH-LOGICAL-h269t-1185ef801c4d38d13250265e3043e73beb4bd400c5d67fd19ae8f883768e363
ISSN 0008-5472
IngestDate Sat Sep 28 07:28:13 EDT 2024
Sun Oct 29 17:06:58 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 16
Keywords Antineoplastic agent
Cell culture
Sensitivity resistance
Tissue specificity
Xeroderma pigmentosum
Ataxia telangiectasia
Normal
Fibroblast
In vitro
Photosensitizer
Phototherapy
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-h269t-1185ef801c4d38d13250265e3043e73beb4bd400c5d67fd19ae8f883768e363
PMID 2969280
PageCount 4
ParticipantIDs pubmed_primary_2969280
pascalfrancis_primary_7855583
PublicationCentury 1900
PublicationDate 1988-08-15
PublicationDateYYYYMMDD 1988-08-15
PublicationDate_xml – month: 08
  year: 1988
  text: 1988-08-15
  day: 15
PublicationDecade 1980
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
PublicationTitle Cancer research (Chicago, Ill.)
PublicationTitleAlternate Cancer Res
PublicationYear 1988
Publisher American Association for Cancer Research
Publisher_xml – name: American Association for Cancer Research
SSID ssj0005105
Score 1.6533569
Snippet Experiments were performed to determine if differences in porphyrin photosensitivity could be observed for cells with varying efficiency in DNA damage repair,...
SourceID pubmed
pascalfrancis
SourceType Index Database
StartPage 4539
SubjectTerms Animals
Antineoplastic agents
Biological and medical sciences
Cattle
Cell Survival - drug effects
Cells, Cultured
Dihematoporphyrin Ether
DNA Repair
General aspects
Hematoporphyrin Photoradiation
Hematoporphyrins - pharmacology
Humans
Lipoproteins, LDL - metabolism
Medical sciences
Pharmacology. Drug treatments
Photochemotherapy
Title Differential cell photosensitivity following porphyrin photodynamic therapy
URI https://www.ncbi.nlm.nih.gov/pubmed/2969280
Volume 48
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT8JAEN4AB-PF-IyomB68kSW0--j2aATFGNQAJt5M292GA6EESvz7zna3D7moBy9Ns32k2fn6zT6-mUHoJggSxqkUOBYBw9T1JQYOjDCT2plG4BCVXnAbTf3ndzEY0mGjsS1m_WXbv1oa2sDWOnL2D9YuXwoNcA42hyNYHY6_svvAVjzJ9FK4XpbvruZplm60UN1WikjA9ulnHoae6m5eayW5vkma8vTdrJZqoMpiEKt11-YGmuebv0bFkbPMYtGrrSk8vIyNwOKuV207TWA0bFrL3Z_x2-R1NBnmgszbng2AkCYmT-iU1tgEYdZU_0BHNUTlIkn7aYWG8BsPC8yoKdrTUxX1-tQklyy4mYo6ButMS5lJgmS9NmXUq1xasY2_4-lK_aEvdJoz0kRN4mod6ODxqdIFWd1r8YlaLRtu4IdJTKWTnflHPg6ZHaIDO4Fwbo3lj1BDLY_R3thKJE7QUx0AjgaAswsApwSAUwLAqQPAsQA4RdP74exuhG3FDDz3eJBhmC0ylcCgI6aSCOkSGOB6nCnSp0T5JFIRjSSwdswk9xPpBqESiRDgZIQinJyh1jJdqnPksIjHIXB16CYxhVdGMRehF_VdoXiiYq-NOt865WNlcqN82J5tozPTSeUFL-CBJ_oXPzx4ifYrhF2hVrbeqg5qbuT2OjfTF8dVXxw
link.rule.ids 315,782,786
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+cell+photosensitivity+following+porphyrin+photodynamic+therapy&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=GOMER%2C+C.+J&rft.au=RUCKER%2C+N&rft.au=MURPHREE%2C+A.+L&rft.date=1988-08-15&rft.pub=American+Association+for+Cancer+Research&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=48&rft.issue=16&rft.spage=4539&rft.epage=4542&rft.externalDBID=n%2Fa&rft.externalDocID=7855583
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon